Disease

Stroke

Review Report on Stroke Target / Biomarker Content of Review Report on Stroke Target / Biomarker
Stroke


About the Disease
Cerebrovascular Disease, also known as cerebrovascular disorder, is related to basal ganglia cerebrovascular disease and stroke, ischemic, and has symptoms including headache, transient ischemic attacks, stereotypic symptoms and angina pectoris. An important gene associated with Cerebrovascular Disease is HOTAIR (HOX Transcript Antisense RNA), and among its related pathways/superpathways are Signal Transduction and Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs). The drugs Acetylcarnitine and Benzocaine have been mentioned in the context of this disorder. Affiliated tissues include brain, bone marrow and heart, and related phenotypes are homeostasis/metabolism and growth/size/body region

Common Targets
G1525 | G2161 | G3785 | G2642 | Monoamine oxidase (MAO) (nonspecified subtype) | G54897 | G762 | G1022 | G105375175 | G9644 | G983 | G6934 | G2904 | G2322 | G2931 | G60 | G8029 | G152 | G246 | G8986 | G3565 | G4524 | NADPH Oxidase (nonspecified subtype) | P48131 | Superoxide dismutase (SOD) (nonspecified subtype) | G1588 | G2950 | G3162 | Fibroblast Growth Factor Receptor (FGFR) (nonspecified subtype) | Histone deacetylase (nonspecified subtype) | G6916 | G9290 | G3177 | G624 | G6524 | G22978 | G11200 | G6326 | G22933 | G2528 | Serine/threonine-protein kinase (PAK) (nonspecified subtype) | G2706 | G3363 | G116511 | G132 | Prostaglandin EP Receptor (nonspecified subtype) | G3684 | P6747 | G106144586 | G1071 | G221692 | G840 | G4023 | G197259 | G2158 | G5028 | P13024 | G6000 | Mitogen-activated protein kinase p38 (MAPK p38) (nonspecified subtype) | G5168 | G158067 | G5294 | G6548 | G1845 | Na+/H+ Exchanger (NHE) (nonspecified subtype) | Corticotropin-Releasing Factor (CRF) Receptor (nonspecified subtype) | G3718 | G4594 | G5243 | G6647 | G1909 | G7450 | G774 | G5023 | G25817 | G5599 | G4353 | G4915 | G64078 | 5-Hydroxytryptamine Receptor 3 (5-HT3 receptor) (nonspecified subtype) | G5144 | G6714 | G51284 | G8514 | G3586 | G1440 | P5768 | Cyclin B (nonspecified subtype) | G3609 | G3716 | G51738 | G2597 | G11243 | G493856 | Kainate Receptor (GluR) (nonspecified subtype) | P5760 | G6790 | G51514 | G1012 | G3309 | P12956 | G6336 | G89781 | Calpain (nonspecified subtype) | G3456 | G114548 | P16092 | G3949 | G5826 | G6097 | G6559 | G4854 | G552 | Metabotropic glutamate (mGluR) receptor (nonspecified subtype) | G716 | G2288 | G51185 | G5163 | Voltage-gated K(v) channel (nonspecified subtype) | G2905 | G5550 | G627 | G2897 | G9536 | P2Y purinoceptor (nonspecified subtype) | G6261 | G3791 | P6176 | G1956 | G8694 | G63826 | G3738 | G2915 | G51311 | G2902 | P18508 | Cyclophilins (nonspecified subtype) | G2049 | Serine/Threonine Kinase (nonspecified subtype) | G23224 | Glycogen phosphorylase (nonspecified subtype) | G361 | G5733 | G902 | G7124 | G4886 | G1017 | G338567 | Kir 3.1/3.4 | Tyrosine-Protein Kinases Src (nonspecified subtype) | G4842 | G52 | G3717 | Cyclin-dependent kinase (nonspecified subtype) | G191 | G4712 | G2784 | G120892 | G241 | Phosphodiesterase 1 (PDE1) (nonspecified subtype) | Interleukin-1 (nonspecified subtype) | G1445 | G4306 | G3551 | CDK5/p25 | G7376 | G4986 | G85369 | G151 | G2312 | G6197 | G1557 | G3752 | G79001 | G5164 | G51194 | G5142 | G553 | G11343 | beta-Secretase (nonspecified subtype) | G10013 | G3163 | Acid-Sensing Ion Channel (ASIC) (nonspecified subtype) | P5859 | G1902 | G9370 | G105377732 | Phospholipase A2 (nonspecified subtype) | G1958 | G3620 | P5755 | G57142 | G1496 | G3786 | G8942 | G3386 | G2053 | G239 | G1/S-specific cyclin-E (nonspecified subtype) | G51293 | G10014 | P11019 | G2561 | G5600 | G1282 | G6319 | G6383 | Phosphodiesterase IV (PDE4) (nonspecified subtype) | G1586 | G6774 | G695 | G801 | G3091 | G187 | G727 | G4869 | G51564 | G6093 | G4988 | G6385 | Heat shock protein 90 (nonspecified subtype) | G949 | Casein kinase I (nonspecified subtype) | G protein-Coupled Inwardly-Rectifying Potassium Channel (GIRK) (nonspecified subtype) | G171425 | G7432 | G2566 | G1153 | G3484 | Alpha-2 Adrenergic receptors (nonspecified subtype) | G1514 | G4314 | G10280 | G9212 | G10062 | G1128 | G1636 | G1830 | G1021 | G2898 | G93974 | G3479 | G64170 | G3758 | Ribonucleoside-diphosphate reductase | G2906 | AMP Deaminase (nonspecified subtype) | G4296 | G10266 | Protein Kinase B (PKB/Akt) (nonspecified subtype) | G3553 | G5793 | Phospholipase C (nonspecified subtype) | G2891 | G3776 | G217 | G50507 | G842 | G3932 | G2280 | Alcohol Dehydrogenase (nonspecified subtype) | G5465 | G1269 | Calcium channel (nonspecified subtype) | G2152 | G1030 | G2912 | G2357 | G5728 | Lipoxygenase (nonspecified subtype) | G1432 | G1441 | G4321 | G5024 | G8698 | alpha-Secretase (nonspecified subtype) | Matrix Metalloproteinase (MMP) (nonspecified subtype) | G4773 | G10846 | G7299 | G10110 | G1020 | Glutamate Transporter (nonspecified subtype) | Calcium-Activated K(Ca) Potassium Channel (nonspecified subtype) | Phosphatidylinositol 3-kinase (PI3K) (nonspecified subtype) | G6609 | G55584 | G3569 | G6550 | G3783 | G5460 | G5654 | P19243 | G9817 | G6536 | G4887 | G10594 | G24145 | Protein Tyrosine Phosphatase (PTP) (nonspecified subtype) | G3375 | Protein kinase C (nonspecified subtype) | G2100 | G136 | G7297 | G23620 | G5291 | G100463486 | G307 | G345 | CDK9/Cyclin T1 | alpha-Adrenoceptor (nonspecified subtype) | Opioid receptor (nonspecified subtype) | Oxysterols receptor LXR (nonspecified subtype) | G2159 | G4921 | Chloride channel (nonspecified subtype) | G255738 | G554 | G57674 | Neurotrophic Factor (nonspecified subtype) | G134 | Acetylcholine Receptors (Nicotinic) (nAChR) (nonspecified subtype) | Adenylate Cyclase (nonspecified subtype) | G463 | G79054 | G51422 | Guanylate cyclase (nonspecified subtype) | G3350 | G3357 | G105375977 | P24881 | P34664 | G7412 | G3156 | G4780 | G3815 | G5604 | G4128 | G7433 | G23411 | G2837 | P16176 | G6329 | G6947 | G4878 | G1813 | P6058 | G766 | G100379251 | Sphingomyelin phosphodiesterase (nonspecified subtype) | G3753 | G6610 | G8856 | P5762 | G3760 | G100048912 | G2696 | G100507053 | G8874 | G1139 | G1910 | G837 | G8444 | G3676 | Integrin alphaIIbbeta3 (fibrinogen gpIIb/IIIa) receptor | G3689 | G19 | G4137 | G719 | G5241 | G100528007 | G3383 | G1952 | G26751 | G1903 | G7852 | G80007 | G5595 | G590 | G3748 | KCNQ Channels (K(v) 7) (nonspecified subtype) | G1859 | G7535 | G51393 | Estrogen receptor (nonspecified subtype) | G835 | G5583 | G150 | P5867 | G166785 | G101928272 | P6320 | G6538 | G6648 | G1025 | G1268 | Orexin receptor (nonspecified subtype) | G1066 | G1742 | G5601 | G3290 | G3486 | G54209 | G5467 | G6095 | P5833 | G1029 | G29108 | P33507 | G8924 | G581 | G2899 | G2562 | 15-Lipoxygenase (nonspecified subtype) | G1803 | G7225 | G5327 | G2918 | G1361 | G142 | G3741 | G406992 | G6948 | G2352 | G5580 | G9927 | Amyloid beta A4 precursor protein-binding family (APP-BP) (nonspecified subtype) | Tyrosine Kinase (nonspecified subtype) | G5340 | G8829 | G66037 | G208 | G857 | G2903 | G346007 | Cysteine Protease (nonspecified subtype) | G3973 | G4099 | G904 | G6262 | G3777 | G3065 | G64805 | G231 | Pyruvate dehydrogenase kinase (nonspecified subtype) | G135 | G51750 | G2982 | G5768 | G120227 | G7046 | G706 | G2147 | G23621 | G841 | G9734 | G1284 | G153 | G6597 | G2295 | Heme Oxygenase (HO) (nonspecified subtype) | Trypsin (nonspecified subtype) | P40594 | G3762 | G7442 | G55759 | G2833 | G1131 | sigma Receptor (nonspecified subtype) | G140 | Triacylglycerol Lipase (TG Lipase) (nonspecified subtype) | G4985 | G5054 | G875 | G55191 | G5143 | G101180901 | G9263 | Kallikrein (nonspecified subtype) | Prostanoid TP receptor (nonspecified subtype) | G3990 | G2043 | G7498 | G10008 | G10803 | P2X Receptor (nonspecified subtype) | G586 | G2346 | G64101 | G823 | G2730 | Peptidylprolyl Isomerase (nonspecified subtype) | G2846 | G10203 | G2952 | CDK1/Cyclin B | beta-Adrenoceptor (nonspecified subtype) | G2932 | G104909134 | G117 | G7226 | G4914 | G54822 | G5742 | Glycogen synthase kinase 3 (GSK-3) (nonspecified subtype) | G1592 | G412 | G5770 | G406971 | G43 | G23704 | P32313 | G368 | G5147 | G5468 | G9971 | G5153 | Elastase (nonspecified subtype) | G1906 | G2057 | G9759 | G56603 | Solute carrier family 29 member (nonspecified subtype) | Actin (nonspecified subtype) | G2324 | G2913 | G3480 | G6662 | G6750 | G4322 | G2678 | Vascular endothelial growth factor receptor (VEGFR) (nonspecified subtype) | G102191832 | G3303 | Serine protease (nonspecified subtype) | G6833 | G5787 | G128 | G1394 | Caspase (nonspecified subtype) | G2166 | G23028 | G1116 | G2099 | G6096 | G9992 | G5138 | G1133 | G3362 | G1195 | G3630 | G7296 | G2260 | G5167 | G2563 | Sodium channel (nonspecified subtype) | G6652 | G2558 | G5265 | G2911 | Heat shock protein 70 (nonspecified subtype) | L-Type calcium channel (nonspecified subtype) | G3784 | G2697 | CDK2/Cyclin A | G898 | Cannabinoid receptor (nonspecified subtype) | G886 | G105372272 | High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7 (nonspecified protein) | G9002 | G10699 | Adenosine receptor (nonspecified subtype) | G2321 | G23235 | G836 | G27346 | Poly [ADP-ribose] polymerase (nonspecified subtype) | G2194 | G3690 | G84446 | G8529 | G5602 | P40377 | Mitogen-Activated Protein Kinase (nonspecified subtype) | G3790 | G2358 | G9149 | G2317 | G5444 | Janus Kinase (nonspecified subtype) | HTR1B | G6427 | G2638 | G9509 | 5-Hydroxytryptamine Receptor 2 (5-HT2) (nonspecified subtype) | G7941 | G9223 | G9451 | Chemokine receptor (nonspecified subtype) | G54583 | G4318 | G5328 | Aurora Kinase (nonspecified subtype) | P16191 | G7054 | G760 | G5141 | G5648 | Hypoxia-Inducible Factor Prolyl Hydroxylase (nonspecified subtype) | P32821 | G4142 | G196 | G4846 | G80279 | G3756 | G2160 | G2555 | Angiotensin receptor (AT) (nonspecified subtype) | G11315 | Cyclooxygenase (COX) (nonspecified subtype) | G154 | Large Conductance BK(Ca) Potassium Channel (Maxi K+ Channel) (nonspecified subtype) | P13475 | CDK2/Cyclin E | CDK7/Cyclin H | alpha1-Adrenoceptor (nonspecified subtype) | G3991 | G7157 | G9475 | P34550 | G2149 | Endothelin receptor (nonspecified subtype) | G6532 | G1579 | G4067 | G2524 | G10019 | G101928496 | G5605 | G1508 | G3818 | G2548 | G5406 | G287 | G186 | G2167 | G50508 | G8654 | Calcium/calmodulin-dependent protein kinase type II (CaMK-II) | G799 | G3558 | Cyclin-dependent kinase inhibitor (nonspecified subtype) | G834 | G2914 | Gamma-glutamyl transferase (nonspecified subtype) | 5-Hydroxytryptamine Receptor (nonspecified subtype) | G351 | G100505841 | G2863 | G57705 | G338 | P6348 | G185 | G4540 | G839 | G8445 | G10038 | alpha-Amylase (nonspecified subtype) | G177 | G718 | Cyclin A (nonspecified subtype) | G10135 | Nitric oxide synthase (NOS) (nonspecified subtype) | G11318 | G375056 | G4907 | G2559 | Ryanodine receptor (nonspecified subtype) | Glutamate Receptor Ionotropic (nonspecified subtype) | G1787 | G4313 | G7275 | G23143 | Collagenase (nonspecified subtype) | cGMP-inhibited 3',5'-cyclic phosphodiesterase 3 (PDE3) (nonspecified subtype) | G156 | P17840 | G2908 | G355 | G56923 | G4323 | G367 | G2030 | G8878 | G6517 | G710 | G11103 | Na+/Ca2+ Exchanger (NCX) (nonspecified subtype) | G4233 | G5136 | G2840 | G6347 | G1594 | G10257 | G5972 | G1401 | G23566 | G5581 | G3356 | G134864 | Mitogen-activated protein kinase (JNK) (nonspecified subtype) | G1524 | G6546 | Dual Specificity Mitogen-Activated Protein Kinase Kinase (MEK) (nonspecified subtype) | G1585 | G101928635 | G1141 | P24924 | G6506 | G2534 | G8989 | G105377134 | Melanocortin receptor (nonspecified subtype) | G7421 | G4048 | G105372798 | G2944 | Glutathione peroxidase (nonspecified subtype) | G64429 | G4843 | Potassium Channels (nonspecified subtype) | G5027 | G8737 | G340061 | Vasoactive intestinal polypeptide receptor (VIP-R) (nonspecified subtype) | Rho kinase (ROCK) (nonspecified subtype) | G1814 | G5150 | Epoxide Hydrolase (nonspecified subtype) | G1129 | Voltage-Gated Calcium Channel alpha-2/delta (nonspecified subtype) | G3745 | G2804 | G1215 | G240 | G7351 | G9388 | G1234 | G84930 | G2993 | G5743 | G387 | G80036 | G5156 | G5266 | G55669 | G5979 | G2146 | G7428 | G2247 | G8639 | P5767 | G1719 | G4129 | G4803 | G23498 | G81792 | G5724 | P10999 | G6531 | G824 | G2740 | G5732 | P16740 | G8564

The "Target / Biomarker Review Report" is a comprehensive and customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about the Target(s) / Biomarker(s) of your choice related to Stroke, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

Other Diseases

Stroke, Hemorrhagic | Stroke, Ischemic | Stromal Corneal Dystrophy | Sturge-Weber Syndrome | Stuttering | Stuve-Wiedemann Syndrome | Subacute Sclerosing Panencephalitis | Subcortical Band Heterotopia | Succinic Semialdehyde Dehydrogenase Deficiency | Sulfite Oxidase Deficiency | Superficial Spreading Melanoma | Supravalvular Aortic Stenosis | Sweet Syndrome | Swine Influenza | Syncope | Syndactyly | Synovitis | Synpolydactyly | Syphilis | Systemic Lupus Erythematosus | Systemic Mastocytosis | T-cell Chronic Lymphocytic Leukemia | T-cell Leukemia | T-cell Lymphoma, Subcutaneous Panniculitis-like | T-cell Prolymphocytic Leukemia | Takayasu's Arteritis | Takenouchi-Kosaki Syndrome | Takotsubo Cardiomyopathy | Tangier Disease | Tardive Dyskinesia | TARP Syndrome | Tatton-Brown-Rahman Syndrome | Tay-Sachs Disease | Temporal Lobe Epilepsy | Temtamy Preaxial Brachydactyly Syndrome | Tendinitis | Tendinopathy | Tenosynovial Giant Cell Tumor | Teratozoospermia | Tetanus | Tetraplegia | Thalassemia | Thalassemia, Beta | Thanatophoric Dysplasia | Thanatophoric Dysplasia Type 1 | Thin Basement Membrane Disease | Thrombasthenia | Thrombocythemia, Essential | Thrombocytopenia | Thromboembolism | Thrombophilia | Thrombophlebitis | Thrombosis | Thrombotic Microangiopathy | Thymoma, Malignant | Thyroid Dysgenesis | Thyroid Dyshormonogenesis | Thyroid Hormone Resistance | Thyroiditis | Thyroiditis, Autoimmune | Thyrotoxic Periodic Paralysis | Tibial Muscular Dystrophy | Tic Disorder | Tietze Syndrome | Tinea | Tinea Versicolor | Tonsillitis | Torticollis | Toxic Epidermal Necrolysis | Toxoplasmosis | Traboulsi Syndrome | Tracheal Disorders | Trachoma | Transcobalamin Deficiency | Transient Bullous Dermolysis Of The Newborn | Transthyretin-related Amyloidosis | Treacher Collins Syndrome | Tremor | Tricho-hepato-enteric Syndrome | Trichomegaly | Trichorhinophalangeal Syndrome | Trichothiodystrophy | Trichotillomania | Trichuriasis | Trigonocephaly | Trimethylaminuria | Triphalangeal Thumb-polysyndactyly Syndrome | Triple A Syndrome | Trismus-pseudocamptodactyly Syndrome | Tuberculosis | Tuberculous Meningitis | Tularemia | Tumoral Calcinosis | Turner's Syndrome | Twin-to-twin Transfusion Syndrome | Tylosis With Esophageal Cancer | Tyrosine Hydroxylase Deficiency | Tyrosinemia | Tyrosinemia Type 1 | Tyrosinemia Type 2 | Ulcerative Colitis | Unverricht-Lundborg Syndrome | Urea Cycle Disorder | Uremia | Uremic Pruritus | Ureteropelvic Junction Obstruction | Urethritis | Urofacial Syndrome | Urolithiasis | Urticaria | Usher Syndrome | Usher Syndrome Type I | Usher Syndrome Type II | Usher Syndrome Type IIC | Usher Syndrome Type III | Uterine Leiomyoma | Uveitis | Uveitis, Anterior | VACTERL Association | VACTERL/VATER Association | Vaginitis | Van Der Knaap Disease | Varices | Varicocele | Vascular Calcification | Vascular Cognitive Impairment | Vasculitis | Veno-occlusive Disease | Venous Insufficiency | Ventricular Septal Defect | Vertebrobasilar Insufficiency | Vertigo | Very Long-chain Acyl-CoA Dehydrogenase Deficiency | Vestibular Disease | VEXAS Syndrome | Vici Syndrome | Viral Meningitis | Vitamin A Deficiency | Vitamin B12 Deficiency | Vitamin D Deficiency | Vitamin K Deficiency | Vitelliform Macular Dystrophy | Vitiligo | Vitreoretinal Degeneration, Snowflake Type | Vitreoretinopathy, Proliferative | Vogt-Koyanagi-Harada Syndrome | Von Hippel-Lindau Disease | Von Willebrand Disease | Vulvovaginitis | Waardenburg Syndrome | Waardenburg Syndrome Type 1 | Waardenburg Syndrome Type 2 | Waardenburg Syndrome Type 2A | Waardenburg Syndrome Type 2E | Waardenburg Syndrome Type 4 | Waardenburg Syndrome Type 4A | Wagner Disease | WAGR Syndrome | Waldenstrom Macroglobulinemia | Walker-Warburg Syndrome | Warsaw Breakage Syndrome | Weill-Marchesani Syndrome | Werner's Syndrome | Whipple's Disease | Wieacker-Wolff Syndrome | Wiedemann-Steiner Syndrome | Williams Syndrome | Wilson's Disease | Wiskott-Aldrich Syndrome | Withdrawal Syndrome | Wolcott-Rallison Syndrome | Wolff-Parkinson-White Syndrome | Wolfram Syndrome | Wolfram Syndrome 2 | Wolman Disease | Woodhouse-Sakati Syndrome | X-linked Acrogigantism | X-linked Charcot-Marie-Tooth Disease | X-linked Creatine Transporter Deficiency | X-linked Myotubular Myopathy | X-linked Sideroblastic Anemia | Xeroderma Pigmentosum | Xeroderma Pigmentosum Variant Type | Yellow Fever | Zellweger Syndrome | Zimmermann-Laband Syndrome | Zollinger-Ellison Syndrome | Zygomycosis